Details for Patent: 6,645,961
✉ Email this page to a colleague
Summary for Patent: 6,645,961
| Title: | Dry granulation formulation for an HIV protease inhibitor |
| Abstract: | This invention relates to a dry granulation capsule formulation of the HIV protease inhibitor, indinavir sulfate, which is useful in the treatment of AIDS, ARC or HIV infection. Processes for making the oral formulation are also disclosed. |
| Inventor(s): | Lui; Chung Y. (Lansdale, PA), Ostovic; Drazen (Lansdale, PA), Katdare; Ashok V. (Norristown, PA), Stelmach; Christine (Tinton Falls, NJ) |
| Assignee: | Merck & Co., Inc. (Rahway, NJ) |
| Application Number: | 09/045,885 |
|
Patent Claim Types: see list of patent claims | Composition; Dosage form; Formulation; Process; |
Drugs Protected by US Patent 6,645,961
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
